---

$13.40

-0.0050 ( -0.04% ) 566.4K

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Open	$13.40
Previous Close	$13.40
Volume	566.4K
Market Cap	$3.52B
Day Range	$13.34 - $13.41
52 Week Range	$5.69 - $13.48
Shares Outstanding	262.60M
Change %	-0.04%
Net Change	▼ -0.0050
Insider Ownership	N/A
Exchange	NYSE
Sector	Basic Materials
Industry	PHARMACEUTICAL PREPARATIONS
IPO Year	2021
Country	United States

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-11-13	Buy	65400.00	COX CARRIE SMITH
2025-11-13	Buy	65400.00	COX CARRIE SMITH
2025-11-13	Buy	65400.00	COX CARRIE SMITH
2025-05-15	Buy	12469.00	COX CARRIE SMITH
2025-05-07	Buy	3500.00	Karp Daniel
2025-05-07	Buy	8045.00	Weaver Kirke
2025-05-07	Buy	5500.00	Falcione Aaron
2025-05-06	Buy	34000.00	Ali Kevin
2025-05-06	Buy	11400.00	WALSH MATTHEW M